Compare AstraZeneca plc (AZN) vs Blackrock Inc (BLK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AstraZeneca plc vs Blackrock Inc — how do they compare? AstraZeneca plc trades at $158.56 (market cap $250.84B), while Blackrock Inc trades at $1,144.15 (market cap $175.22B). The key difference: AstraZeneca plc is the larger of the two by market cap, and Blackrock Inc pays the higher dividend (2.03%). Which is the better fit depends on your goals.
| AZN | BLK | |
|---|---|---|
Market Cap | $250.84B | $175.22B |
Sector | Health | Financials |
52-Week High | $209.48 | $1.20K |
52-Week Low | $147.06 | $922.90 |
Enterprise Value | $278.12B | $176.32B |
Dividend Yield | 1.97% | 2.03% |
Volume | — | 641,547 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AstraZeneca plc
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Read more on AZN →About Blackrock Inc
BlackRock, Inc. provides investment management services to institutional clients and to retail investors through various investment vehicles. The Company manages funds, as well as offers risk management services. BlackRock serves governments, companies, and foundations worldwide.
Read more on BLK →
